Home > Financial Ratios > THEMIS MEDICARE

THEMIS MEDICARE
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for THEMIS MEDICARE
Please provide your vote to see the results

THEMIS MEDICARE Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) -4.52-28.74-22.7392.3735.77

What is the latest Core EBITDA Growth ratio of THEMIS MEDICARE ?

The latest Core EBITDA Growth ratio of THEMIS MEDICARE is -4.52 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar2025-4.52
Mar2024-28.74
Mar2023-22.73
Mar202292.37
Mar202135.77

How is Core EBITDA Growth of THEMIS MEDICARE Trending?

Years Core EBITDA Growth % Change
Mar2025 -4.52
Negative
Mar2024 -28.74
Negative
Mar2023 -22.73
Negative
Mar2022 92.37
158.23
Mar2021 35.77 -

Other Financial Ratios of THEMIS MEDICARE


Compare Core EBITDA Growth ratio of peers of THEMIS MEDICARE

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
THEMIS MEDICARE ₹960.1 Cr 0.4% 3.3% -26% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹433,620.0 Cr 1% -0.9% 6.8% Stock Analytics
DIVIS LABORATORIES ₹176,087.0 Cr 1.8% -2.3% 1.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹154,837.0 Cr 3.7% 6.5% 44.9% Stock Analytics
CIPLA ₹112,194.0 Cr 0% 4.7% -8% Stock Analytics
DR REDDYS LABORATORIES ₹106,328.0 Cr -0.2% 0.7% -3.4% Stock Analytics


THEMIS MEDICARE Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
THEMIS MEDICARE

0.4%

3.3%

-26%

SENSEX

1.7%

1.3%

-7.3%


You may also like the below Video Courses